We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-4.65%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$226M
AUM Growth
+$15.4M
Cap. Flow
+$22.3M
Cap. Flow %
9.86%
Top 10 Hldgs %
35.32%
Holding
73
New
13
Increased
28
Reduced
11
Closed
15

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$5.86M
2
BDX icon
Becton Dickinson
BDX
+$5.09M
3
ABT icon
Abbott
ABT
+$4.95M
4
AET
Aetna Inc
AET
+$4.82M
5
MCK icon
McKesson
MCK
+$4.2M

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$7.14M
2
VTRS icon
Viatris
VTRS
+$4.87M
3
HNT
HEALTH NET INC
HNT
+$4.22M
4
RAD
Rite Aid Corporation
RAD
+$3.96M
5
AMGN icon
Amgen
AMGN
+$3.71M

Sector Composition

Rank Sector Weight
1 Healthcare 86.82%
2 Financials 4.72%
3 Energy 1.73%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AET
1
DELISTED
Aetna Inc
AET
$10.7M 4.72%
95,000
+45,000
+90% +$4.82M
HCA icon
2
HCA Healthcare
HCA
$87.8B
$9.76M 4.32%
125,000
-15,000
-11% -$1.05M
UNH icon
3
UnitedHealth
UNH
$378B
$9.67M 4.28%
75,000
+25,000
+50% +$2.96M
UHS icon
4
Universal Health Services
UHS
$10.3B
$9.35M 4.14%
75,000
+10,000
+15% +$1.12M
MCK icon
5
McKesson
MCK
$98.8B
$8.02M 3.55%
51,000
+26,000
+104% +$4.2M
ALXN
6
DELISTED
Alexion Pharmaceuticals
ALXN
$6.96M 3.08%
50,000
+20,000
+67% +$2.94M
BDX icon
7
Becton Dickinson
BDX
$46.7B
$6.83M 3.02%
46,125
+35,875
+350% +$5.09M
HUM icon
8
Humana
HUM
$44.4B
$6.4M 2.83%
35,000
+15,000
+75% +$2.6M
CNC icon
9
Centene
CNC
$31.3B
$6.16M 2.73%
200,000
+120,000
+150% +$3.58M
GILD icon
10
Gilead Sciences
GILD
$162B
$5.97M 2.64%
+65,000
New +$5.86M
WBA
11
DELISTED
Walgreens Boots Alliance
WBA
$5.9M 2.61%
70,000
+43,512
+164% +$3.47M
BSX icon
12
Boston Scientific
BSX
$71.8B
$5.64M 2.5%
300,000
– –
CI icon
13
Cigna
CI
$74.6B
$5.49M 2.43%
40,000
– –
CHE icon
14
Chemed
CHE
$7.18B
$5.42M 2.4%
40,000
+15,000
+60% +$2.03M
ZBH icon
15
Zimmer Biomet
ZBH
$18.7B
$5.33M 2.36%
51,500
+30,900
+150% +$2.99M
ABT icon
16
Abbott
ABT
$185B
$5.23M 2.31%
+125,000
New +$4.95M
BMY icon
17
Bristol-Myers Squibb
BMY
$134B
$5.11M 2.26%
80,000
+5,000
+7% +$315K
BMRN icon
18
BioMarin Pharmaceuticals
BMRN
$11.6B
$4.95M 2.19%
60,000
+32,114
+115% +$2.61M
WCG
19
DELISTED
Wellcare Health Plans, Inc.
WCG
$4.64M 2.05%
50,000
+15,000
+43% +$1.24M
THC icon
20
Tenet Healthcare
THC
$20.1B
$4.63M 2.05%
160,000
+35,000
+28% +$911K
REGN icon
21
Regeneron Pharmaceuticals
REGN
$78B
$4.51M 1.99%
12,500
+7,500
+150% +$3.09M
TMO icon
22
Thermo Fisher Scientific
TMO
$214B
$4.25M 1.88%
30,000
-5,000
-14% -$670K
AGN
23
DELISTED
Allergan plc
AGN
$4.02M 1.78%
15,000
-2,500
-14% -$716K
CELG
24
DELISTED
Celgene Corp
CELG
$4M 1.77%
40,000
– –
LHCG
25
DELISTED
LHC Group LLC
LHCG
$3.91M 1.73%
110,000
+22,295
+25% +$820K
1
2 3

Similar funds

RSF
Rik Saylor Financial Fairfield, Ohio $132M AUM 16.04% 1-Year Est. Return
VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
DQRIM
Dale Q Rice Investment Management Vancouver, Washington $132M AUM 45.8% 1-Year Est. Return

Sivik Global Healthcare's Q1 2016 Portfolio in Review

As of Q1 2016, Sivik Global Healthcare held 73 positions worth $226M, up 7.3% from $211M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Sivik Global Healthcare deployed $22.3M of net new capital in Q1 2016, opening 13 new positions and adding to 28 existing holdings. Its largest new stake was Gilead Sciences: 65,000 shares worth $5.97M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 87% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Rite Aid Corporation, an estimated $3.96M trimmed.

  • Sivik Global Healthcare's largest Q1 2016 buy was Gilead Sciences: 65,000 shares worth $5.97M.
  • Sivik Global Healthcare added most to Becton Dickinson in Q1 2016, an estimated $5.09M increase.
  • Sivik Global Healthcare's biggest Q1 2016 reduction was Rite Aid Corporation, cutting an estimated $3.96M.
  • Sivik Global Healthcare fully exited Cardinal Health in Q1 2016, selling an estimated $7.14M.
  • Sivik Global Healthcare's ten largest holdings make up 35% of its $226M portfolio in Q1 2016.
  • Sivik Global Healthcare opened 13 new positions and closed 15 in Q1 2016.
  • Sivik Global Healthcare's portfolio value rose 7.3% quarter-over-quarter to $226M.

Based on Sivik Global Healthcare's 13F filing for Q1 2016, filed 6 May 2016.